These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19934076)

  • 21. Assessment of hallucinations in Parkinson's disease using a novel scale.
    Wada-Isoe K; Ohta K; Imamura K; Kitayama M; Nomura T; Yasui K; Nakaso K; Nakashima K
    Acta Neurol Scand; 2008 Jan; 117(1):35-40. PubMed ID: 18095953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hallucinations in Parkinson's disease--a study of forty three patients.
    Gupta M; Singh G; Khwaja GA; Mehndiratta MM
    J Assoc Physicians India; 2004 Sep; 52():703-6. PubMed ID: 15839446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing functional performance in people with Parkinson disease.
    Brusse KJ; Zimdars S; Zalewski KR; Steffen TM
    Phys Ther; 2005 Feb; 85(2):134-41. PubMed ID: 15679464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postural instability in idiopathic Parkinson's disease: discriminating fallers from nonfallers based on standardized clinical measures.
    Landers MR; Backlund A; Davenport J; Fortune J; Schuerman S; Altenburger P
    J Neurol Phys Ther; 2008 Jun; 32(2):56-61. PubMed ID: 18645292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of pain and health-related quality of life in Korean patients with Parkinson's disease.
    Roh JH; Kim BJ; Jang JH; Seo WK; Lee SH; Kim JH; Oh K; Park KW; Lee DH; Koh SB
    Acta Neurol Scand; 2009 Jun; 119(6):397-403. PubMed ID: 18976321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.
    Martínez-Martín P; Gil-Nagel A; Gracia LM; Gómez JB; Martínez-Sarriés J; Bermejo F
    Mov Disord; 1994 Jan; 9(1):76-83. PubMed ID: 8139608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA; Grosset DG
    Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of cognitive impairment in a population of patients with Parkinson's disease by means of the mini mental Parkinson test].
    Parrao-Díaz T; Chaná-Cuevas P; Juri-Claverías C; Kunstmann C; Tapia-Núñez J
    Rev Neurol; 2005 Mar 16-31; 40(6):339-44. PubMed ID: 15795869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative responsiveness of Parkinson's disease scales to change over time.
    Schrag A; Spottke A; Quinn NP; Dodel R
    Mov Disord; 2009 Apr; 24(6):813-8. PubMed ID: 19199355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric attributes of the SCOPA-COG Brazilian version.
    Carod-Artal FJ; Martínez-Martin P; Kummer W; Ribeiro Lda S
    Mov Disord; 2008 Jan; 23(1):81-7. PubMed ID: 17987646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acupuncture therapy for the symptoms of Parkinson's disease.
    Shulman LM; Wen X; Weiner WJ; Bateman D; Minagar A; Duncan R; Konefal J
    Mov Disord; 2002 Jul; 17(4):799-802. PubMed ID: 12210879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease.
    Kummer A; Cardoso F; Teixeira AL
    Mov Disord; 2008 Sep; 23(12):1739-43. PubMed ID: 18661550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life in patients with Parkinson's disease.
    Behari M; Srivastava AK; Pandey RM
    Parkinsonism Relat Disord; 2005 Jun; 11(4):221-6. PubMed ID: 15878582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between motor subtypes and psychopathology in Parkinson's disease.
    Reijnders JS; Ehrt U; Lousberg R; Aarsland D; Leentjens AF
    Parkinsonism Relat Disord; 2009 Jun; 15(5):379-82. PubMed ID: 18977165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Validation of the Japanese version of the Parkinson's Disease Questionnaire].
    Kohmoto J; Ohbu S; Nagaoka M; Suzukamo Y; Kihira T; Mizuno Y; Ito YM; Hith M; Yamaguchi T; Ohashi Y; Fukuhara S; Kondo T
    Rinsho Shinkeigaku; 2003 Mar; 43(3):71-6. PubMed ID: 12820553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
    Stebbins GT; Goetz CG
    Mov Disord; 1998 Jul; 13(4):633-6. PubMed ID: 9686766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relation of sexual dysfunction to depression and anxiety in patients with Parkinson's disease.
    Özcan T; Benli E; Demir EY; Özer F; Kaya Y; Haytan CE
    Acta Neuropsychiatr; 2015 Feb; 27(1):33-7. PubMed ID: 25385451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version.
    Carod-Artal FJ; Martinez-Martin P; Vargas AP
    Mov Disord; 2007 Jan; 22(1):91-8. PubMed ID: 17094102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.